| 摘要 |
<p>The invention is directed to a compound of the formula: (I) wherein substitutions at R<1>, R<2> , R<3> - R<12>,< >and Y are set forth in the specification; pharmaceutical compositions comprising said compound, methods of treating or preventing a Hepatitis C viral infection in a mammal comprising contacting the mammal with an effective amount of said compound or pharmaceutical compositions including said compound and methods of inhibiting replication of a Hepatitis C virus comprising contacting the HCV virus with an effective amount of said compound or pharmaceutical compositions including said compound.</p> |
